Diagnostic and prognostic significance of brief limited intermittent psychotic symptoms (BLIPS) in individuals at ultra high risk

Schizophrenia Bulletin

Volumn 43, Issue 1, 2017, Pages 48-56

  Fusar Poli, Paolo ^a,b   Cappucciati, Marco ^a,c   De Micheli, Andrea ^a,c   Rutigliano, Grazia ^a,d   Bonoldi, Ilaria ^a,b   Tognin, Stefania ^a,b   Ramella Cravaro, Valentina ^a,e   Castagnini, Augusto ^f   McGuire, Philip ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

BLIPS; Brief psychosis; CAARMS; Diagnosis; Prevention; Psychosis; Risk; Schizophrenia; UHR

Indexed keywords

CANNABINOID;

ADULT; ARTICLE; BRIEF LIMITED INTERMITTENT PSYCHOTIC SYMPTOMS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; ELECTRONIC HEALTH RECORD; FEMALE; HIGH RISK PATIENT; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DISEASE ASSESSMENT; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; PROSPECTIVE STUDY; PSYCHOSIS; SCHIZOPHRENIA; SOCIAL ASPECT; CLASSIFICATION; CROSS-SECTIONAL STUDY; INTERNATIONAL CLASSIFICATION OF DISEASES; LONGITUDINAL STUDY; PATHOPHYSIOLOGY; PSYCHOTIC DISORDERS; RISK ASSESSMENT; YOUNG ADULT;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LONGITUDINAL STUDIES; MALE; PSYCHOTIC DISORDERS; RISK ASSESSMENT; SCHIZOPHRENIA; YOUNG ADULT;

EID: 85014211167     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbw151     Document Type: Article

References (41)

1. Fusar-Poli P, Borgwardt S, Bechdolf A, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 2013;70:107-120.
2. Yung A, Yuen H, McGorry P, et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. ANZJP. 2005;39:964-971.
3. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull. 1996;22:283-303.
4. Fusar-Poli P, Van Os J. Lost in transition: setting psychosis trehsold in prodromal research. Acta Psychiatr Scand. 2013;127:248-252.
5. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29:703-715.
6. Fusar-Poli P, Cappucciati M, Borgwardt S, et al. Heterogeneity of risk for psychosis within subjects at clinical high risk: meta-analytical stratification JAMA Psychiatry. 2016;73:113-120.
7. Fusar-Poli P, Cappucciati M, Bonoldi I, et al. Prognosis of brief psychotic episodes: a meta-analysis. JAMA Psychiatry. 2016;73:211-220.
8. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29:703-715.
9. Fusar-Poli P, Cappucciati M, Bonoldi I, et al. Prognosis of brief psychotic episodes: a meta-analysis. JAMA Psychiatry. 2016;73:211-220.
10. Fusar-Poli P, Cappucciati M, Rutigliano G, et al. Towards a standard psychometric diagnostic interview for subjects at ultra high risk of psychosis: CAARMS versus SIPS. Psychiatry J. 2016;2016:7146341.
11. Fusar-Poli P, Byrne M, Badger S, Valmaggia LR, McGuire PK. Outreach and support in south London (OASIS), 2001- 2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis. Eur Psychiatry. 2013;28:315-326.
12. Fusar-Poli P, Frascarelli M, Valmaggia L, et al. Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study. Psychol Med. 2015;45:1327-1339.
13. McGlashan TH, Walsh B, Wood SJ. The Psychosis-Risk Syndrome. Handbook for Diagnosis and Follow-up. New York, NY: Oxford University Press; 2010.
14. Orrell M, Yard P, Handysides J, Schapira R. Validity and reliability of the Health of the Nation Outcome Scales in psychiatric patients in the community. Brit J Psychiatry. 1999;174:409-412.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text rev. Washington, DC: American Psychiatric Association; 2000.
16. Stewart R, Soremekun M, Perera G, et al. The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data. BMC Psychiatry. 2009;9:51.
17. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Amer Statist Assn. 1958;53:457-481.
18. Greenwood M. The Natural Duration of Cancer. London, UK: HMSO; 1926.
19. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526.
20. Cornblatt B, Carrión R, Auther A, et al. Psychosis prevention: a modified clinical high risk perspective from the Recognition and Prevention (RAP) Program [published online ahead of print June 5, 2015]. Am J Psychiatry.
21. Hosmer D, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: Wiley; 2000.
22. Akaike H. Likelihood of a model and information criteria. J Econom. 1981;16:3-14.
23. Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med. 1992;11:2093-2109.
24. Obuchowski NA, Lieber ML, Wians FH Jr. ROC curves in clinical chemistry: uses, misuses, and possible solutions. Clin Chem. 2004;50:1118-1125.
25. Hosmer W, Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data. New York, NY: Wiley & Sons; 1999.
26. World Health Organization. International Classification of Diseases, Tenth Revision (ICD-10). Geneva, Switzerland: WHO; 1990.
27. Fusar-Poli P, Yung AR, McGorry P, van Os J. Lessons learned from the psychosis high-risk state: towards a general staging model of prodromal intervention. Psychol Med. 2014;44:17-24.
28. Queirazza F, Semple DM, Lawrie SM. Transition to schizophrenia in acute and transient psychotic disorders. Brit J Psychiatry. 2014;204:299-305.
29. Carrion R, Correll C, Auther A, Cornblatt B. A severitybased clinical staging model for the psychosis prodrome: longitudinal findings from New York RAP study. Schizophr Bull. 2017;43:64-74.
30. Castagnini A, Foldager L. Epidemiology, course and outcome of acute polymorphic psychotic disorder: implications for ICD-11. Psychopathology. 2014;47:202-206.
31. Fusar-Poli P, Rutigliano G, Stahl D, et al. Long-term validity of the at risk mental state (ARMS) for predicting nonpsychotic mental disorders. Eur Psychiatry. In press.
32. Castagnini AC, Munk-Jorgensen P, Bertelsen A. Short-term course and outcome of acute and transient psychotic disorders: differences from other types of psychosis with acute onset. Int J Soc Psychiatry. 2016;62:51-56.
33. Fusar-Poli P, Bechdolf A, Taylor MJ, et al. At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ ICD diagnostic outcomes in individuals at high clinical risk. Schizophr Bull. 2013;39:923-932.
34. Webb JR, Addington J, Perkins DO, et al. Specificity of incident diagnostic outcomes in patients at clinical high risk for psychosis. Schizophr Bull. 2015;41:1066-1075.
35. Fusar-Poli P, Cappucciati M, Rutigliano G, et al. Diagnostic stability of ICD/DSM first episode psychosis diagnoses: meta-analysis. Schizophr Bull. 2017;43:48-56.
36. Cornblatt BA, Carrion RE. Deconstructing the psychosis risk syndrome: moving the field of prevention forward. JAMA Psychiatry. 2016;73:105-106.
37. McGlashan TH, Fenton WS. Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophr Bull. 1993;19:71-84.
38. Addington J, Liu L, Perkins D, Carrion RE, Keefe R, Woods SW. The role of cognition and social functioning as predictors in the transition to psychosis for youth with attenuated psychotic symptoms. Schizophr Bull. 2017;43:57-63.
39. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res. 2004;67:131-142.
40. Francey SM, Nelson B, Thompson A, et al. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Schizophr Res. 2010; 119:1-10.
41. Yung AR, Nelson B, Thompson A, Wood SJ. The psychosis threshold in Ultra High Risk (prodromal) research: is it valid? Schizophr Res. 2010;120:1-6.